img

Global Female Sexual Dysfunction Treatment Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Female Sexual Dysfunction Treatment Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm.
Female Sexual Dysfunction Treatment report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Female Sexual Dysfunction Treatment market is projected to reach US$ 819.4 million in 2034, increasing from US$ 122.6 million in 2022, with the CAGR of 30.6% during the period of 2024 to 2034. Demand from Sexual Desire Disorders and Sexual Arousal Disorders are the major drivers for the industry.
The increasing prevalence of chronic diseases is one of the key factors that will drive the growth of the market during the forecast period. Women suffering from chronic health conditions such as diabetes may also be diagnosed with sexual dysfunction. Clinical indications, including hypertension, obesity, metabolic syndrome, and atherogenic dyslipidemia, of chronic conditions such as diabetes, are the risk factors for sexual dysfunctions in women. The rising prevalence of chronic health conditions in women will increase the incidence of female sexual dysfunctions. This will provide considerable growth opportunities to market participants.

Mental health conditions such as depression are being recognized as critical health issues mostly among women. As a result, many pharmaceutical companies are releasing drugs and therapies to treat these conditions leading to an increase in the consumption of antidepressants, antipsychotics, and antiepileptics. Moreover, there is also an increase in the consumption of contraceptives. These drugs cause sexual dysfunctions in women.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Female Sexual Dysfunction Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


AMAG Pharmaceuticals Inc.
Duchesnay Inc.
Emotional Brain BV
Novo Nordisk AS
Sprout Pharmaceuticals Inc.
Segment by Type
Non-hormonal Therapy
Hormonal Therapy

Segment by Application


Sexual Desire Disorders
Sexual Arousal Disorders
Orgasm Disorders
Sexual Pain Disorders
Post-orgasmic Diseases
Pelvic Floor Dysfunction
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Female Sexual Dysfunction Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Female Sexual Dysfunction Treatment introduction, etc. Female Sexual Dysfunction Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Female Sexual Dysfunction Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Female Sexual Dysfunction Treatment
1.1 Female Sexual Dysfunction Treatment Market Overview
1.1.1 Female Sexual Dysfunction Treatment Product Scope
1.1.2 Female Sexual Dysfunction Treatment Market Status and Outlook
1.2 Global Female Sexual Dysfunction Treatment Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Female Sexual Dysfunction Treatment Market Size by Region (2024-2034)
1.4 Global Female Sexual Dysfunction Treatment Historic Market Size by Region (2024-2024)
1.5 Global Female Sexual Dysfunction Treatment Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Female Sexual Dysfunction Treatment Market Size (2024-2034)
1.6.1 North America Female Sexual Dysfunction Treatment Market Size (2024-2034)
1.6.2 Europe Female Sexual Dysfunction Treatment Market Size (2024-2034)
1.6.3 Asia-Pacific Female Sexual Dysfunction Treatment Market Size (2024-2034)
1.6.4 Latin America Female Sexual Dysfunction Treatment Market Size (2024-2034)
1.6.5 Middle East & Africa Female Sexual Dysfunction Treatment Market Size (2024-2034)
2 Female Sexual Dysfunction Treatment Market by Type
2.1 Introduction
2.1.1 Non-hormonal Therapy
2.1.2 Hormonal Therapy
2.2 Global Female Sexual Dysfunction Treatment Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Female Sexual Dysfunction Treatment Historic Market Size by Type (2024-2024)
2.2.2 Global Female Sexual Dysfunction Treatment Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Female Sexual Dysfunction Treatment Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Female Sexual Dysfunction Treatment Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Female Sexual Dysfunction Treatment Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Female Sexual Dysfunction Treatment Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Female Sexual Dysfunction Treatment Revenue Breakdown by Type (2024-2034)
3 Female Sexual Dysfunction Treatment Market Overview by Application
3.1 Introduction
3.1.1 Sexual Desire Disorders
3.1.2 Sexual Arousal Disorders
3.1.3 Orgasm Disorders
3.1.4 Sexual Pain Disorders
3.1.5 Post-orgasmic Diseases
3.1.6 Pelvic Floor Dysfunction
3.1.7 Other
3.2 Global Female Sexual Dysfunction Treatment Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Female Sexual Dysfunction Treatment Historic Market Size by Application (2024-2024)
3.2.2 Global Female Sexual Dysfunction Treatment Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Female Sexual Dysfunction Treatment Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Female Sexual Dysfunction Treatment Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Female Sexual Dysfunction Treatment Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Female Sexual Dysfunction Treatment Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Female Sexual Dysfunction Treatment Revenue Breakdown by Application (2024-2034)
4 Female Sexual Dysfunction Treatment Competition Analysis by Players
4.1 Global Female Sexual Dysfunction Treatment Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Female Sexual Dysfunction Treatment as of 2022)
4.3 Date of Key Players Enter into Female Sexual Dysfunction Treatment Market
4.4 Global Top Players Female Sexual Dysfunction Treatment Headquarters and Area Served
4.5 Key Players Female Sexual Dysfunction Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Female Sexual Dysfunction Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AMAG Pharmaceuticals Inc.
5.1.1 AMAG Pharmaceuticals Inc. Profile
5.1.2 AMAG Pharmaceuticals Inc. Main Business
5.1.3 AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Products, Services and Solutions
5.1.4 AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue (US$ Million) & (2024-2024)
5.1.5 AMAG Pharmaceuticals Inc. Recent Developments
5.2 Duchesnay Inc.
5.2.1 Duchesnay Inc. Profile
5.2.2 Duchesnay Inc. Main Business
5.2.3 Duchesnay Inc. Female Sexual Dysfunction Treatment Products, Services and Solutions
5.2.4 Duchesnay Inc. Female Sexual Dysfunction Treatment Revenue (US$ Million) & (2024-2024)
5.2.5 Duchesnay Inc. Recent Developments
5.3 Emotional Brain BV
5.3.1 Emotional Brain BV Profile
5.3.2 Emotional Brain BV Main Business
5.3.3 Emotional Brain BV Female Sexual Dysfunction Treatment Products, Services and Solutions
5.3.4 Emotional Brain BV Female Sexual Dysfunction Treatment Revenue (US$ Million) & (2024-2024)
5.3.5 Novo Nordisk AS Recent Developments
5.4 Novo Nordisk AS
5.4.1 Novo Nordisk AS Profile
5.4.2 Novo Nordisk AS Main Business
5.4.3 Novo Nordisk AS Female Sexual Dysfunction Treatment Products, Services and Solutions
5.4.4 Novo Nordisk AS Female Sexual Dysfunction Treatment Revenue (US$ Million) & (2024-2024)
5.4.5 Novo Nordisk AS Recent Developments
5.5 Sprout Pharmaceuticals Inc.
5.5.1 Sprout Pharmaceuticals Inc. Profile
5.5.2 Sprout Pharmaceuticals Inc. Main Business
5.5.3 Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Products, Services and Solutions
5.5.4 Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue (US$ Million) & (2024-2024)
5.5.5 Sprout Pharmaceuticals Inc. Recent Developments
6 North America
6.1 North America Female Sexual Dysfunction Treatment Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Female Sexual Dysfunction Treatment Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Female Sexual Dysfunction Treatment Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Female Sexual Dysfunction Treatment Market Dynamics
11.1 Female Sexual Dysfunction Treatment Industry Trends
11.2 Female Sexual Dysfunction Treatment Market Drivers
11.3 Female Sexual Dysfunction Treatment Market Challenges
11.4 Female Sexual Dysfunction Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Female Sexual Dysfunction Treatment Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Female Sexual Dysfunction Treatment Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Female Sexual Dysfunction Treatment Market Size Share by Region (2024-2024)
Table 4. Global Female Sexual Dysfunction Treatment Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Female Sexual Dysfunction Treatment Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Female Sexual Dysfunction Treatment Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Female Sexual Dysfunction Treatment Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Female Sexual Dysfunction Treatment Revenue Market Share by Type (2024-2024)
Table 9. Global Female Sexual Dysfunction Treatment Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Female Sexual Dysfunction Treatment Revenue Market Share by Type (2024-2034)
Table 11. North America Female Sexual Dysfunction Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Female Sexual Dysfunction Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Female Sexual Dysfunction Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Female Sexual Dysfunction Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Female Sexual Dysfunction Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Female Sexual Dysfunction Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Female Sexual Dysfunction Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Female Sexual Dysfunction Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Female Sexual Dysfunction Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Female Sexual Dysfunction Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Female Sexual Dysfunction Treatment Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Female Sexual Dysfunction Treatment Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Female Sexual Dysfunction Treatment Revenue Market Share by Application (2024-2024)
Table 24. Global Female Sexual Dysfunction Treatment Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Female Sexual Dysfunction Treatment Revenue Market Share by Application (2024-2034)
Table 26. North America Female Sexual Dysfunction Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Female Sexual Dysfunction Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Female Sexual Dysfunction Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Female Sexual Dysfunction Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Female Sexual Dysfunction Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Female Sexual Dysfunction Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Female Sexual Dysfunction Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Female Sexual Dysfunction Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Female Sexual Dysfunction Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Female Sexual Dysfunction Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Female Sexual Dysfunction Treatment Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Female Sexual Dysfunction Treatment Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Female Sexual Dysfunction Treatment as of 2022)
Table 39. Date of Key Players Enter into Female Sexual Dysfunction Treatment Market
Table 40. Global Female Sexual Dysfunction Treatment Key Players Headquarters and Area Served
Table 41. Female Sexual Dysfunction Treatment Product Solution and Service
Table 42. Global Female Sexual Dysfunction Treatment Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. AMAG Pharmaceuticals Inc. Basic Information List
Table 45. AMAG Pharmaceuticals Inc. Description and Business Overview
Table 46. AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Products, Services and Solutions
Table 47. Revenue (US$ Million) in Female Sexual Dysfunction Treatment Business of AMAG Pharmaceuticals Inc. (2024-2024)
Table 48. AMAG Pharmaceuticals Inc. Recent Developments
Table 49. Duchesnay Inc. Basic Information List
Table 50. Duchesnay Inc. Description and Business Overview
Table 51. Duchesnay Inc. Female Sexual Dysfunction Treatment Products, Services and Solutions
Table 52. Revenue (US$ Million) in Female Sexual Dysfunction Treatment Business of Duchesnay Inc. (2024-2024)
Table 53. Duchesnay Inc. Recent Developments
Table 54. Emotional Brain BV Basic Information List
Table 55. Emotional Brain BV Description and Business Overview
Table 56. Emotional Brain BV Female Sexual Dysfunction Treatment Products, Services and Solutions
Table 57. Revenue (US$ Million) in Female Sexual Dysfunction Treatment Business of Emotional Brain BV (2024-2024)
Table 58. Emotional Brain BV Recent Developments
Table 59. Novo Nordisk AS Basic Information List
Table 60. Novo Nordisk AS Description and Business Overview
Table 61. Novo Nordisk AS Female Sexual Dysfunction Treatment Products, Services and Solutions
Table 62. Revenue (US$ Million) in Female Sexual Dysfunction Treatment Business of Novo Nordisk AS (2024-2024)
Table 63. Novo Nordisk AS Recent Developments
Table 64. Sprout Pharmaceuticals Inc. Basic Information List
Table 65. Sprout Pharmaceuticals Inc. Description and Business Overview
Table 66. Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Products, Services and Solutions
Table 67. Revenue (US$ Million) in Female Sexual Dysfunction Treatment Business of Sprout Pharmaceuticals Inc. (2024-2024)
Table 68. Sprout Pharmaceuticals Inc. Recent Developments
Table 69. North America Female Sexual Dysfunction Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 70. North America Female Sexual Dysfunction Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 71. Europe Female Sexual Dysfunction Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 72. Europe Female Sexual Dysfunction Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 73. Asia-Pacific Female Sexual Dysfunction Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 74. Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Region (2024-2024) & (US$ Million)
Table 75. Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Region (2024-2034) & (US$ Million)
Table 76. Asia-Pacific Female Sexual Dysfunction Treatment Market Share by Region (2024-2024)
Table 77. Asia-Pacific Female Sexual Dysfunction Treatment Market Share by Region (2024-2034)
Table 78. Latin America Female Sexual Dysfunction Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 79. Latin America Female Sexual Dysfunction Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 80. Latin America Female Sexual Dysfunction Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 81. Middle East & Africa Female Sexual Dysfunction Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 82. Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 83. Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 84. Female Sexual Dysfunction Treatment Market Trends
Table 85. Female Sexual Dysfunction Treatment Market Drivers
Table 86. Female Sexual Dysfunction Treatment Market Challenges
Table 87. Female Sexual Dysfunction Treatment Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Female Sexual Dysfunction Treatment Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Female Sexual Dysfunction Treatment Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Female Sexual Dysfunction Treatment Market Share by Regions: 2022 VS 2034
Figure 4. Global Female Sexual Dysfunction Treatment Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Female Sexual Dysfunction Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Female Sexual Dysfunction Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Female Sexual Dysfunction Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Female Sexual Dysfunction Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Female Sexual Dysfunction Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Non-hormonal Therapy
Figure 11. Global Non-hormonal Therapy Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Hormonal Therapy
Figure 13. Global Hormonal Therapy Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Global Female Sexual Dysfunction Treatment Market Size Share by Type: 2022 & 2034
Figure 15. North America Female Sexual Dysfunction Treatment Revenue Market Share by Type (2024-2034)
Figure 16. Europe Female Sexual Dysfunction Treatment Revenue Market Share by Type (2024-2034)
Figure 17. Asia-Pacific Female Sexual Dysfunction Treatment Revenue Market Share by Type (2024-2034)
Figure 18. Latin America Female Sexual Dysfunction Treatment Revenue Market Share by Type (2024-2034)
Figure 19. Middle East and Africa Female Sexual Dysfunction Treatment Revenue Market Share by Type (2024-2034)
Figure 20. Sexual Desire Disorders Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 21. Sexual Arousal Disorders Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 22. Orgasm Disorders Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Sexual Pain Disorders Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Post-orgasmic Diseases Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Pelvic Floor Dysfunction Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 26. Other Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 27. Global Female Sexual Dysfunction Treatment Market Size Share by Application: 2022 & 2034
Figure 28. North America Female Sexual Dysfunction Treatment Revenue Market Share by Application (2024-2034)
Figure 29. Europe Female Sexual Dysfunction Treatment Revenue Market Share by Application (2024-2034)
Figure 30. Asia-Pacific Female Sexual Dysfunction Treatment Revenue Market Share by Application (2024-2034)
Figure 31. Latin America Female Sexual Dysfunction Treatment Revenue Market Share by Application (2024-2034)
Figure 32. Middle East and Africa Female Sexual Dysfunction Treatment Revenue Market Share by Application (2024-2034)
Figure 33. Female Sexual Dysfunction Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 34. Global Top 5 and Top 10 Players Female Sexual Dysfunction Treatment Market Share in 2022
Figure 35. North America Female Sexual Dysfunction Treatment Market Share by Country (2024-2034)
Figure 36. U.S. Female Sexual Dysfunction Treatment Market Size (2024-2034) & (US$ Million)
Figure 37. Canada Female Sexual Dysfunction Treatment Market Size (2024-2034) & (US$ Million)
Figure 38. Germany Female Sexual Dysfunction Treatment Market Size (2024-2034) & (US$ Million)
Figure 39. France Female Sexual Dysfunction Treatment Market Size (2024-2034) & (US$ Million)
Figure 40. U.K. Female Sexual Dysfunction Treatment Market Size (2024-2034) & (US$ Million)
Figure 41. Italy Female Sexual Dysfunction Treatment Market Size (2024-2034) & (US$ Million)
Figure 42. Russia Female Sexual Dysfunction Treatment Market Size (2024-2034) & (US$ Million)
Figure 43. Nordic Countries Female Sexual Dysfunction Treatment Market Size (2024-2034) & (US$ Million)
Figure 44. Asia-Pacific Female Sexual Dysfunction Treatment Market Share by Region (2024-2034)
Figure 45. China Female Sexual Dysfunction Treatment Market Size (2024-2034) & (US$ Million)
Figure 46. Japan Female Sexual Dysfunction Treatment Market Size (2024-2034) & (US$ Million)
Figure 47. South Korea Female Sexual Dysfunction Treatment Market Size (2024-2034) & (US$ Million)
Figure 48. Southeast Asia Female Sexual Dysfunction Treatment Market Size (2024-2034) & (US$ Million)
Figure 49. India Female Sexual Dysfunction Treatment Market Size (2024-2034) & (US$ Million)
Figure 50. Australia Female Sexual Dysfunction Treatment Market Size (2024-2034) & (US$ Million)
Figure 51. Latin America Female Sexual Dysfunction Treatment Market Share by Country (2024-2034)
Figure 52. Mexico Female Sexual Dysfunction Treatment Market Size (2024-2034) & (US$ Million)
Figure 53. Brazil Female Sexual Dysfunction Treatment Market Size (2024-2034) & (US$ Million)
Figure 54. Middle East & Africa Female Sexual Dysfunction Treatment Market Share by Country (2024-2034)
Figure 55. Turkey Female Sexual Dysfunction Treatment Market Size (2024-2034) & (US$ Million)
Figure 56. Saudi Arabia Female Sexual Dysfunction Treatment Market Size (2024-2034) & (US$ Million)
Figure 57. UAE Female Sexual Dysfunction Treatment Market Size (2024-2034) & (US$ Million)
Figure 58. Bottom-up and Top-down Approaches for This Report